找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Management of Breast Diseases; Ismail Jatoi,Achim Rody Book 2016Latest edition Springer International Publishing Switzerland 2016 Breast I

[复制链接]
楼主: 自治
发表于 2025-3-27 00:08:40 | 显示全部楼层
发表于 2025-3-27 02:49:14 | 显示全部楼层
发表于 2025-3-27 08:28:39 | 显示全部楼层
Surgical Considerations in the Management of Primary Invasive Breast Cancer,tomy (CPM), and breast-conserving surgery (BCS). Following BCS, radiation therapy (RT) is often required to reduce the risk of ipsilateral breast tumor recurrence, although older patients with indolent tumors may not require radiotherapy after BCS. Moreover, radiotherapy is required for selected hig
发表于 2025-3-27 09:26:46 | 显示全部楼层
Management of the Axilla,nd accepted as standard of care worldwide. Dual localization methods with blue dye and radioisotope are associated with optimal performance parameters such as shorter learning curve, higher identification rates and low false-negative rates. Several issues relating to surgical technique and choice of
发表于 2025-3-27 16:31:24 | 显示全部楼层
Breast Reconstructive Surgery,mmetrical breast mound after mastectomy. Breast reconstruction can be at the time of mastectomy or as a delayed procedure. Options for reconstruction include prosthetic implants, autologous tissue, or both. Implant reconstruction is a relatively simple and effective method of breast reconstruction,
发表于 2025-3-27 20:43:08 | 显示全部楼层
The Role of Radiotherapy in Breast Cancer Management, recurrent carcinoma of the breast. Despite the technical limitations of the early equipment, tumor shrinkage and at times complete elimination of the tumor were noticed. However, the full potential of radiation therapy could not be achieved in those early days because of the limited knowledge regar
发表于 2025-3-28 01:04:14 | 显示全部楼层
发表于 2025-3-28 04:39:19 | 显示全部楼层
Endocrine Therapy,ausal women, tamoxifen is the standard in low-risk patients, providing a significant reduction in both risk of recurrence and BC mortality; the addition of ovarian function suppression (OFS) to tamoxifen or the aromatase inhibitor (AI) Exemestane is recommended in patients at higher risk of relapse.
发表于 2025-3-28 07:04:14 | 显示全部楼层
发表于 2025-3-28 13:46:58 | 显示全部楼层
http://image.papertrans.cn/m/image/622451.jpg
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-25 12:54
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表